PLAT and androgen insensitivity syndrome: Between 1991 and 1995, a NINDS sponsored randomized trial [1] was conducted to assess the safety and efficacy of recombinant tissue plasminogen activator (tPA) in patients with AIS, within 3 hours of stroke onset.